Homepage-Banners-2018-Trends_Rev2.jpg

How are we doing? Tracking pharma product launch ROI through global and local challenges

Posted by Andre Moa on Aug 23, 2016 12:00:00 PM

How are we doing Tracking pharma product launch ROI through global and local challenges.jpg

With product margins under pressure in an increasingly complex marketplace, pharmaceutical companies must ensure that each component of their product launch plan makes a meaningful contribution to return on investment (ROI).

 

Read More

Topics: Pharma ROI

Maintaining pharma ROI as market access bites

Posted by Andre Moa on Jun 15, 2016 12:00:00 PM

How can renewed R&D productivity, delivering better targeted, more effective compounds in areas of unmet need, result in lower average margins for pharmaceutical product launches?

Read More

Topics: Pharma market access, Pharma ROI

Making launches count: pharma ROI under strain

Posted by Andre Moa on Apr 21, 2016 12:00:00 PM

 

Medicines need to make a profit. Even the staunchest pharma industry critics, those who would rather see healthcare business as an oxymoron, would have difficulty coming up with a model that did not involve some element of return on investment (ROI) from the money and resources invested in drug discovery, development and commercialisation.

Read More

Topics: Pharma ROI

2014 review: How did our pharma launch trend predictions fare?

Posted by Andre Moa on Dec 22, 2014 11:41:00 AM

 

At the start of 2014, we predicted the top 5 pharma trends for 2014 that we expected to affect your launch planning. Now that the year is drawing to a close, we thought it would be interesting to look back at our predictions and reflect on the year. 

Read More

Topics: Pharma ROI, Pharma trends, launch trends

5 signs your launch team is not collaborating effectively

Posted by Andre Moa on Nov 14, 2014 2:46:00 PM

 

Read More

Topics: Pharma ROI, global launch team, collaboration